Dr. Michael Green

Dr. Michael Green

CEO, Founder

Founder and CEO of Desupervised, where we co-develop uncertainty-aware AI solutions with companies. Theoretical physicist with 25 years building neural networks and a vocal advocate for Bayesian methods and uncertainty quantification.

20 posts

  1. Bayesian Statistics

    Bayesian priors and Ridge regression

    Showing the equivalence of Bayesian priors and Ridge regression

  2. Bayesian Statistics

    Choose your optimization algorithm carefully

    How does the choice of optimization result impact how long time it takes to find the correct solution

  3. Bayesian Statistics

    Confidence intervals - Not what you think

    Confidence intervals actually says nothing at all about the probability of the value being in the interval

  4. Bayesian Statistics

    Deep Evidential Modeling

    Deep Evidential Modeling for safe, robust and accurate machine learning applications

  5. Bayesian Statistics

    Identifiability and granularity for time series models

    Is it better to aggregate sparse data or does the granularity add value

  6. Bayesian Statistics

    Impact of bimodality in regression problems

    A few thoughts on apparent bimodality for regression problems!

  7. Drug Discovery

    Launching the ComNav

    Why we are launching ComNav, a holistic business measurement & optimization platform

  8. Bayesian Statistics

    The apparent success of the maximum likelihood principle

    The maximum likelihood principle is modeling without assumptions, and there is no such thing. The assumption of no assumption is a flawed assumption.

  9. Bayesian Statistics

    The importance of context

    The importance of context when building models

  10. Bayesian Statistics

    The insignificance of significance

    Statistical significance has always held a slightly magical status in the research community, this is misguided ans should be stopped

  11. Bayesian Statistics

    The truth about priors and overfiting

    Learn about the effect of week and strong priors and how it effects overfitting

  12. Applied ML

    Top 3 reasons why you should consider an external AI team

    Artificial intelligence (AI) has rapidly become one of the most transformative technologies of the 21st century. Learn why you should consider an external AI team to accelerate your adaptation

  13. Bayesian Statistics

    What does the prior actually do in a Bayesian analysis?

    How the prior and posterior effects the likelihood in Bayesian inference, and why setting the correct priors are important.

  14. Marketing Mix Modeling

    On the long term effects of marketing and brand models

    Understand the how marketing impact brand awareness

  15. Marketing Mix Modeling

    Holistic Business Modeling Supersedes Business Science Models

    Maximizing Growth and Profitability: How Holistic Business Modeling and Optimization Can Transform Your Business

  16. Customer Experience

    NPS: On the importance of customer experience for insurance companies

    Customer experience refers to the overall perception of a customer’s interactions with a company. It includes elements such as the ease of use of a company’s products or services, the quality of customer service, and the overall feeling of satisfaction a customer has with the company.

  17. Bayesian Statistics

    On the fallacy of A/B testing

    A/B testing is a commonly used method for determining the effectiveness of different variations of a product or marketing campaign. However, despite its widespread use, A/B testing has several limitations that make it a flawed methodology, particularly when compared to bespoke machine learning models.

  18. Customer Experience

    Top 3 reasons why the ROI on your CX investments is hard to measure and prove

    or CX investments, whose primary output is typically measured in Net Promoter Score (NPS) this presents a challenge to measure the ROI

  19. Drug Discovery

    Drug Discovery using Equivariant Graph Neural Networks

    Equivariant Graph Neural Networks that predict protein binding sites blindly, plus ligand pose and orientation, benchmarked against Qvina-W in early AIChemy work.

  20. Drug Discovery

    Desupervised & RG Discovery Receive Eurostars Grant

    Desupervised and RG Discovery have partnered to develop AI-powered drug discovery tools, supported by a Eurostars R&D grant.

Ready for the next step?

Tell us the decision you need to make with confidence. We'll tell you honestly whether a model can help.